Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) Equity Ratio (2016 - 2025)

Jaguar Health (JAGX) has disclosed Equity Ratio for 11 consecutive years, with 0.09 as the latest value for Q3 2025.

  • On a quarterly basis, Equity Ratio fell 60.67% to 0.09 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.09, a 60.67% decrease, with the full-year FY2024 number at 0.12, up 26.0% from a year prior.
  • Equity Ratio was 0.09 for Q3 2025 at Jaguar Health, down from 0.14 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.46 in Q1 2021 to a low of 0.03 in Q4 2022.
  • A 5-year average of 0.17 and a median of 0.13 in 2023 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: surged 1012.51% in 2021, then crashed 112.87% in 2022.
  • Jaguar Health's Equity Ratio stood at 0.22 in 2021, then plummeted by 112.87% to 0.03 in 2022, then surged by 436.84% to 0.1 in 2023, then increased by 26.0% to 0.12 in 2024, then decreased by 27.51% to 0.09 in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Equity Ratio are 0.09 (Q3 2025), 0.14 (Q2 2025), and 0.02 (Q1 2025).